Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
CSL Behring (Australia) Pty Ltd,Garadacimab,Hereditary angioedema (HAE),Garadacimab (Andembry),Options for investment,Community and Hospital,
